EVALUATION OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN HEPATOCELLULAR CARCINOMA. FMHR [Internet]. 2025 Sep. 29 [cited 2026 Apr. 23];3(7):1259-72. Available from: https://fmhr.net/index.php/fmhr/article/view/1225